Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
20 participants
INTERVENTIONAL
2009-09-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Satiety Response of Four Dietary Fibers
NCT01233024
Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers
NCT00958399
Satiety Response of Short Chain Fructooligosaccharide
NCT01100788
Satiety Study of a Carbohydrate Meal to a Highly Viscous Gel Meal
NCT01875627
Effect of Resistant Wheat Starch on Subjective Appetite and Food Intake in Healthy Adults
NCT02689791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Dextrin Control
Placebo- Fiber free control
Dextrin control administered in a muffin treatment.
Hi-maize resistant starch 9g
Hi-maize resistant starch 9g
Hi-maize resistant starch 9g
9g Hi-maize resistant starch administered in a muffin treatment.
Novalose 330 resistant starch 9g
Novalose 330 resistant starch 9g
Novalose 330 resistant starch 9g
9g Novalose 330 resistant starch administered in a muffin treatment.
4.5g Hi-maize and 4.5g Novalose 330
4.5g Hi-maize and 4.5g Novalose 330
4.5g Hi-maize resistant starch and 4.5g Novalose 330
4.5g Hi-maize and 4.5g Novalose 330 in a muffin treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo- Fiber free control
Dextrin control administered in a muffin treatment.
Hi-maize resistant starch 9g
9g Hi-maize resistant starch administered in a muffin treatment.
Novalose 330 resistant starch 9g
9g Novalose 330 resistant starch administered in a muffin treatment.
4.5g Hi-maize resistant starch and 4.5g Novalose 330
4.5g Hi-maize and 4.5g Novalose 330 in a muffin treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-64 years
* Non-smoking
* Not taking medication
* Non dieting (weight stable in prior 3 months)
* BMI 18-27
* English literacy
Exclusion Criteria
* Food allergies to ingredients found in the study products
* BMI \<18 or \>27
* Diagnosed cardiovascular disease, renal disease, hepatic disease, or diabetes mellitus
* Cancer in previous 5 years
* Any gastrointestinal disease or condition
* Recent bacterial infection (\< 3months)
* Recent or concurrent participation in an intervention research study
* History of drug or alcohol abuse in prior 6 months
* Use of lipid lowering, anti-hypertensive, or anti-inflammatory steroid medication
* Eating disorder
* Vegetarians
* People who eat more than approximately 15 grams of fiber per day
* Women who are pregnant or lactating
* Women with irregular menstrual cycles
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanne L Slavin, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
806M37445
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.